Status:
RECRUITING
Young Survivors at Kantonsspital Aarau, Switzerland
Lead Sponsor:
Kantonsspital Aarau
Conditions:
Childhood Cancer
Late Effects
Eligibility:
All Genders
Brief Summary
The Young Survivors at Kantonsspital Aarau project assesses the prevalence and severity of late effects in survivors of childhood and adolescent cancer according to the modified CTCAE criteria prospec...
Detailed Description
Background: Around 250-300 children and adolescents below the age of 21 years are newly diagnosed with cancer in Switzerland every year. Research led to remarkable progress in survival in the last de...
Eligibility Criteria
Inclusion
- Group A:
- Children and adolescents who:
- have been treated for cancer in the Division of Oncology-Hematology, Department of Pediatrics, at the Kantonsspital Aarau,
- have been diagnosed at age 0-18 years,
- are still in regular follow-up care at the Kantonsspital Aarau,
- have finished cancer treatment and entered follow-up care, and
- signed informed consent
- Group B:
- Adolescents and adults who:
- fulfill the same inclusion criteria as Group A
- are not in regular follow-up care anymore
Exclusion
- Childhood Cancer Survivors who:
- are in a palliative situation or
- have not given consent for further use of medical data
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 15 2072
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04811794
Start Date
March 15 2021
End Date
March 15 2072
Last Update
August 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau
Aarau, Switzerland